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Abstract
Radiotherapy is the treatment of choice for solid tumors including pancreatic cancer, but the effectiveness of treatment is
limited by radiation resistance. Resistance to chemotherapy or radiotherapy is associated with reduced mitochondrial
respiration and drugs that stimulate mitochondrial respiration may decrease radiation resistance. The objectives of this
study were to evaluate the potential of (-)-epicatechin to stimulate mitochondrial respiration in cancer cells and to
selectively sensitize cancer cells to radiation. We investigated the natural compound (-)-epicatechin for effects on
mitochondrial respiration and radiation resistance of pancreatic and glioblastoma cancer cells using a Clark type oxygen
electrode, clonogenic survival assays, and Western blot analyses. (-)-Epicatechin stimulated mitochondrial respiration and
oxygen consumption in Panc-1 cells. Human normal fibroblasts were not affected. (-)-Epicatechin sensitized Panc-1, U87,
and MIA PaCa-2 cells with an average radiation enhancement factor (REF) of 1.7, 1.5, and 1.2, respectively. (-)-Epicatechin did
not sensitize normal fibroblast cells to ionizing radiation with a REF of 0.9, suggesting cancer cell selectivity. (-)-Epicatechin
enhanced Chk2 phosphorylation and p21 induction when combined with radiation in cancer, but not normal, cells. Taken
together, (-)-epicatechin radiosensitized cancer cells, but not normal cells, and may be a promising candidate for pancreatic
cancer treatment when combined with radiation.
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Introduction
Radiotherapy is ideal for many solid tumors because of its
localized cytotoxic effect. Radiation resistance, however, is a
common problem which is responsible for recurrence of tumors in
cancer patients [1]. The Warburg effect, in which mitochondrial
respiration is suppressed even in the presence of oxygen, and
aerobic glycolysis is stimulated, is believed to mediate resistance to
chemotherapy and radiotherapy in solid tumors [2,3]. Treatment
with ionizing radiation stimulates mitochondrial respiration and
increases reactive oxygen species (ROS) production in cancer cells
[4].
Previous reports have suggested a reduced risk of cancer in
patients regularly consuming fruits and vegetables [5]. Flavonoids
are a ubiquitous class of polyphenolic compounds that are present
in fruits and vegetables and comprise several groups of compounds
such as flavanols, flavones, flavonols, isoflavones, flavanones,
anthocyanidins, and proanthocyanidins [4,6]. A number of
beneficial health effects, such as cancer prevention are linked to
flavonoids in the diet [7]. Moreover, flavonoids were shown to
sensitize cancer cells to chemotherapy and radiotherapy, but more
often have been shown to exhibit radioprotective effects on normal
tissues [8–11]. (-)-Epicatechin is a monomeric flavanol that is a
natural compound found in many fruits and vegetables, in
particular in cocoa and green tea [6,12], and it exhibits several
beneficial effects to human health [13]. A recent study by our
group showed that (-)-epicatechin stimulated mitochondrial
respiration and increased mitochondrial mass in mice [14].
The ability of the flavanol (-)-epicatechin to stimulate mito-
chondrial respiration and increase mitochondrial mass in a mouse
model [14], together with an earlier study showing that radiation
stimulates mitochondrial respiration in cancer cells [4], lead us to
hypothesize that (-)-epicatechin may sensitize cancer cells to
radiotherapy, because both counteract Warburg metabolism. The
objectives of this study were to examine the ability of (-)-
epicatechin to stimulate mitochondrial respiration in cancer cells
and to examine the ability of (-)-epicatechin to selectively sensitize
cancer cells to radiation. We here show that (-)-epicatechin
stimulated cytochrome c oxidase (COX) activity and mitochon-
drial respiration in pancreatic cancer cells. In addition, (-)-
epicatechin sensitized pancreatic cancer and glioblastoma cells,
but not normal fibroblasts, to radiation. (-)-Epicatechin in
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combination with ionizing radiation stimulated Chk2 (checkpoint
kinase 2) phosphorylation, p21 expression, and increased apopto-
sis, in cancer cells. These results suggest that (-)-epicatechin
exhibits the potential to improve the therapeutic outcome for
cancer patients by augmenting conventional radiotherapy.
Materials and Methods
(-)-Epicatechin
(-)-Epicatechin was obtained from Sigma-Aldrich as compound
HPLC-purified from green tea ($98% purity) (#E4018). A 2 mM
stock solution of (-)-epicatechin was made in PBS and aliquots
were stored at 280uC. The results of freshly prepared (-)-
epicatechin were consistent with 280uC stocks over the course
of this study. Testing for generation of reactive oxygen species in
cells by (-)-epicatechin-breakdown products after storage at280uC
was negative. Sodium pyruvate in DMEM used for cell culture
serves as an effective scavenger of potential oxidants from
nutraceuticals such as (-)-epicatechin [15].
Cells and cell culture
Panc-1 cells, MIA PaCa-2 cells, U87 cells, and human normal
fibroblasts were purchased from the American Type Culture
Collection and used at low passage (Manassas, VA). U87 cells are
a model cell line for human glioblastoma-astrocytoma. Panc-1 cells
and MIA PaCa-2 cells are model cell lines for human pancreatic
epithelial carcinoma. Fibroblasts are a model cell line for normal
human cells. Cells were cultured and maintained in Dulbecco’s
Modified Eagle’s Medium (DMEM) (high glucose, with pyruvate)
supplemented with 10% fetal bovine serum (FBS) and 2 mM L-
glutamine in absence of antibiotics. Fibroblasts were passaged after
dissociation with 0.05% trypsin/EDTA and other cell lines were
dissociated with 0.25% trypsin/EDTA. Cell lines were routinely
screened for mycoplasma contamination and found to be negative.
Oxygen consumption
Oxygen consumption was assayed by measuring COX activity
which accounts for 90% of all cellular oxygen consumption. COX
activity was analyzed in Panc-1 cells with a micro-Clark-type
oxygen electrode in a closed chamber (Oxygraph System;
Hansatech, Norfolk, UK) at 25uC. Panc-1 cells were seeded into
T-150 flasks and on the next day, cells were treated with different
concentrations of (-)-epicatechin for 1 h, then harvested and
solubilized in 10 mM HEPES (pH 7.4), 40 mM KCl, 1%Tween-
20, 1 mM oligomycin, 1 mM PMSF,10 mM KF, 2 mM EGTA,
and 1 mM Na3VO4. COX activity was measured in the presence
of 20 mM ascorbate and 200 mM substrate cytochrome c from
cow heart (Sigma-Aldrich). Oxygen consumption was recorded on
a computer and analyzed with the Oxygraph software. Protein
concentration was determined with the DC protein assay kit (Bio-
Rad, Hercules, CA,). COX activity is defined as nanomols O2
consumed per minute per milligram total protein.
Clonogenic survival assay
Cells were seeded into T-25 flasks at 56105 cells per flask. On
the next day, cells were exposed to 0–200 mM (-)-epicatechin for
1 h and then irradiated with 0–8 Gy with a Pantak 320 kV
orthovoltage unit at 0.86 Gy per min and 10 mA. Twenty-four
hours after irradiation, cells were trypsinized, counted, and plated
at predetermined clonal densities. Two weeks later, cells were fixed
with a methanol/acetic acid mixture (7:1) and stained with crystal
violet. Colony counting was done manually and data were
analyzed by determining the surviving fraction at each dose of
radiation. Cell survival curves were fit to a linear-quadratic model
and radiation enhancement factors (REF) are derived as the area
under the control (no drug) curve divided by the area under the
test (with drug) curve [16].
Western blot analysis
Cells were exposed to 0–200 mM (-)-epicatechin for 1 h and
then irradiated with 0 or 6 Gy. Twenty-four hours after
irradiation, cells were harvested and lysed in 1% SDS, Halt
Protease and Phosphatase Inhibitor Cocktail, Phosphatase Inhib-
itor Cocktail 3 (Sigma, Cat. No. P 0044), Phosphatase Inhibitor
Cocktail 2 (Sigma, Cat. No. P 5726), 10 mM, pH 7.4, 2 mM
Na3VO4, 1 mM NaF, and 1.7 mM Na4P2O7. Protein content was
determined using a BCA assay (Thermo Scientific). Samples for
phospho-Chk2 (Thr68) and p21 were denatured by boiling with
Figure 1. (-)-Epicatechin is a flavanol that selectively stimulates mitochondrial respiration in pancreatic cancer cells. (A) Oxygen
consumption by cytochrome c oxidase (COX) from Panc-1 cells exposed to different (-)-epicatechin concentrations. Turnover is defined as consumed
O2 (nM)/(min O total protein (mg)). Respiration rates are increased by (-)-epicatechin in a concentration-dependent manner. *p,0.05, compared to
0 mM (-)-epicatechin. (B) Oxygen consumption by cytochrome c oxidase (COX) from human normal fibroblast (HNF) cells exposed to 0 or 100 mM (-)-
epicatechin. Respiration rates are not increased by 100 mM (-)-epicatechin.
doi:10.1371/journal.pone.0088322.g001
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26 Laemmli buffer supplemented with 10% b-mercaptoethanol,
while samples for mitochondrial proteins were mixed with 26
Laemmli buffer supplemented with 10% b-mercaptoethanol and
shaken on a rocker at room temperature for 30 min. Thirty mg of
protein was loaded per well using 4–20% mini-PROTEANH
TGXTM precast gels (Bio-Rad) and then transferred to PVDF
membranes using a Trans-Blot Turbo Plus system (Bio-Rad). After
transfer, membranes were blocked with 5% non-fat dry milk for
1 h at room temperature then incubated overnight with primary
anti-P-Chk2 (Thr68), anti-p21, anti-caspase 3 anti-b-actin, anti-
GAPDH (1:1000–1:5000; Cell Signaling Technologies, Boston,
MA), oxidative phosphorylation (OxPhos) complex I NDUFB6
subunit, OxPhos complex II subunit 70 kDa Fp, OxPhos complex
III core subunit I, cytochrome c, OxPhox complex IV subunit I, or
OxPhos complex V a subunit (1:2000–1:8000; MitoSciences,
Eugene, OR). Membranes were washed with Tris buffered saline
with 0.1% Tween-20 (TBS-T), incubated with secondary anti-
mouse or anti-rabbit antibodies (1:4000; Cell Signaling Technol-
ogies) washed again and incubated with SuperSignal West Pico
Chemiluminescent Substrate for exposure to x-ray film. Protein
bands were quantitated using Quantity One version 4.6.7 (Bio-
Rad).
Statistical analysis
All experiments were repeated at least three times. Clonogenic
experiments were conducted in triplicate. Results are presented as
mean 6 SEM. Statistical analyses were performed using
GraphPad Prism version 6 (GraphPad Software for Science, Inc,
San Diego, CA) with the Mann-Whitney test, Student’s t-test, or
one-way ANOVA, where appropriate. Post-hoc Bonferroni’s
multiple comparisons test was conducted on significant ANOVA
results. Results are considered significant when p,0.05. Error bars
represent 6 SEM.
Results
(-)-Epicatechin stimulates mitochondrial respiration
We have previously shown that (-)-epicatechin stimulates
mitochondrial respiration in normal mouse muscle tissues [14].
To examine whether (-)-epicatechin could stimulate mitochondrial
respiration in cancer cells, we examined the activity of COX by
evaluating the rate of oxygen consumption in Panc-1 cells. COX
transfers electrons from cytochrome c (Cytc) to molecular oxygen,
and ‘charges’ the mitochondria by pumping protons across the
inner mitochondrial membrane that are used later for ATP
generation. The Cytc/COX reaction is the proposed rate-limiting
step of the electron transport chain in vivo [17,18], thus
Figure 3. (-)-Epicatechin does not sensitize normal cells to radiation. (A) 20 mM (-)-Epicatechin does not sensitize HNF cells to radiation
(REF = 0.9). (B) (-)-Epicatechin alone does not inhibit colony formation in HNF (p.0.05).
doi:10.1371/journal.pone.0088322.g003
Figure 2. (-)-Epicatechin sensitizes cancer cells to radiation. (A) (-)-Epicatechin sensitizes Panc-1 cells to radiation with an average REF = 1.7 (B)
(-)-Epicatechin sensitizes U87 cells to radiation with an average REF of 1.5. (C) (-)-Epicatechin sensitizes MIA PaCa-2 cells to radiation with an average
REF = 1.2.
doi:10.1371/journal.pone.0088322.g002
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controlling the overall rate of cellular respiration. (-)-Epicatechin
stimulated COX activity in a dose dependent manner in
pancreatic cancer cells when used at concentrations of up to
200 mM (Figure 1A, p,0.05). At 200 mM (-)-epicatechin, mito-
chondrial respiration was increased by 59% from 15.7 to
25.0 nmol O2/min per milligram protein.
To determine whether stimulation of mitochondrial respiration
by (-)-epicatechin could occur in normal, non-cancerous cell types,
we treated human normal fibroblasts (HNF) with epicatechin and
measured COX activity. No significant increase in O2 consump-
tion was observed after 100 mM treatment (Fig. 1B). These data
show that (-)-epicatechin selectivity stimulates mitochondrial
respiration in cancer cells.
(-)-Epicatechin sensitizes cancer cells to ionizing radiation
Increased mitochondrial respiration due to (-)-epicatechin
treatment may reverse Warburg metabolism and thus sensitize
cancer cells to radiation. To test this, we examined the effect of (-)-
epicatechin on clonogenic survival of Panc-1, U87, and MIA
PaCa-2 cancer cell lines. (-)-Epicatechin significantly enhanced
Figure 4. The effect of (-)-epicatechin on ETC protein expression in combination with radiation. (A) A representative blot for ETC protein
expression in Panc-1 cells that were treated with 0–200 mM (-)-epicatechin and 0 or 6 Gy. (B) (-)-Epicatechin alone does not significantly change ETC
protein expression. Protein levels are normalized to the untreated control. (B) (-)-Epicatechin induced minimal changes in ETC protein expression
when combined with 6 Gy. Values were normalized to 6 Gy alone, and * p,0.05 relative to 6 Gy/0 mM (-)-epicatechin.
doi:10.1371/journal.pone.0088322.g004
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radiosensitivity in Panc-1 cells at doses from 2 to 8 Gy (p = 0.0001,
Fig. 2A). In U87 cells, (-)-epicatechin also significantly enhanced
radiosensitivity at doses from 2 to 8 Gy (p= 0.0001, Fig. 2B).
Similar results were found in the MIA PaCa-2 cell line, in which (-
)-epicatechin produced significant radiosensitization at each dose
tested (p= 0.0001, Fig. 2C). Cell survival curves were fit to a linear
quadratic model. In Panc-1 cells, the surviving fraction at 2 Gy
was 98%, whereas (-)-epicatechin treatment significantly reduced
the the surviving fraction to 58% (p= 0.001). In U87 cells, the
surviving fraction at 2 Gy was 79% and (-)-epicatechin signifi-
cantly reduced survival to 51% (p= 0.021). In MIA PaCa-2 cells,
the surviving fraction at 2 Gy was 67%, whereas (-)-epicatechin
treatment significantly reduced the surviving fraction at 2 Gy to
52% (p= 0.029). The enhancement of radiation-induced cell death
or radiation enhancement factor (REF) was 1.7 for Panc-1, 1.5 for
U87, and 1.2 for MIA PaCa-2 cells. These data show that (-)-
epicatechin radiosensitizes cancers of multiple types in vitro.
(-)-Epicatechin does not sensitize HNF cells to radiation
To test whether (-)-epicatechin radiosensitization is selective for
cancer cells, we examined the effect of (-)-epicatechin on HNF
cells. (-)-Epicatechin at 20 mM did not sensitize HNF cells to
radiation with a REF of 0.9 (Figure 3A). Neither did (-)-epicatechin
alone decrease clonogenic survival of HNF cells (Figure 3B). These
data show that (-)-epicatechin is selective for cancer cells and thus
may not increase normal tissue toxicity when combined with
radiation.
Effect of (-)-epicatechin on electron transport chain (ETC)
protein expression
Previous studies showed that increased mitochondrial respira-
tion via (-)-epicatechin application is associated with a small but
significant upregulation of ETC protein complexes in vivo [14].
We performed Western blot analysis for all OxPhos complexes
using antibodies for a key subunit of each complex (NDUFP,
70 kDa FP, core1, COX1, ATP synthase a) in Panc-1 cells treated
with 0–200 mM (-)-epicatechin prior to exposure to 0 or 6 Gy. (-)-
Epicatechin alone did not significantly change the expression of
any of the ETC proteins in Panc-1 cells (Figure 4A–B). Combining
(-)-epicatechin with 6 Gy had a modest effect on complex I
(NDUFP) at 200 mM and complex III core subunit 1 at 100 mM
(Figure 4A and C, p= 0.0006). These data suggest that (-)-
epicatechin, in this cancer cell line, does not trigger large changes
in mitochondrial OxPhos complexes levels or mediate radiosen-
sitization through large changes in the levels of ETC regulatory
subunits.
(-)-Epicatechin and radiation stimulate checkpoint kinase
2 phosphorylation and p21 expression in Panc-1 but not
HNF cells
Phosphorylation of checkpoint kinase protein 2 (p-Chk2) at
threonine 68 and the overexpression of p21 are implicated in
DNA damage response and radiosensitization [19,20]. We
analyzed p21 expression and Chk2 phosphorylation in Panc-1
cells treated with 0 or 20 mM (-)-epicatechin after exposure to 0 or
6 Gy. (-)-Epicatechin alone did not cause any change in p21 levels
or Chk2 phosphorylation 24 h after treatment. However, combi-
nation of (-)-epicatechin and 6 Gy treatment stimulated p21
expression (Figure 5A, p= 0.0005) and Chk2 phosphorylation
(Figure 5B, p = 0.042). The expression of p21 was increased 62%
and P-Chk2 (Thr68) levels increased 43% in irradiated cells
treated with (-)-epicatechin, compared to cells receiving radiation
alone.
Figure 5. (-)-Epicatechin stimulates checkpoint kinase protein 2 phosphorylation at threonine 68 and p21 expression in Panc-1
cells. (A) (-)-Epicatechin stimulates p21 expression. Protein levels in 20 mM (-)-epicatechin treated samples were normalized to samples treated with
6 Gy. (B) 20 mM (-)-epicatechin stimulates Chk2 phosphorylation. Protein levels in (-)-epicatechin treated samples were normalized to samples that
were treated with 6 Gy, and *p,0.05.
doi:10.1371/journal.pone.0088322.g005
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We then investigated P-Chk2 and p21 in HNF cells after
treatment with (-)-epicatechin and radiation since HNF cells are
not radiosensitized (Fig. 3). In contrast to Panc-1 cancer cells,
combination (-)-epicatechin plus 6 Gy treatment reduced p21
expression by 15% (Fig. 6A, p = 0.03). Chk2 phosphorylation was
unchanged (Fig. 6B). These data suggest that (-)-epicatechin
radiosensitizes cancer cells by perturbations of cell cycle and
checkpoint responses to radiation.
(-)-Epicatechin and radiation stimulate cleavage of
caspase 3 in Panc-1 cells
Caspase 3 is critical for execution of apoptosis. To examine the
possibility that (-)-epicatechin sensitizes cancer cells to radiation by
inducing apoptosis, we performed Western blot analysis for pro-
caspase 3 and cleaved caspase 3 in Panc-1 cells exposed for
72 hours to 0 or 20 m (-)-epicatechin and 0 or 6 Gy of radiation.
Panc-1 cells exposed to (-)-epicatechin showed increased pro-
caspase 3 expression and cells treated (-)-epicatechin and/or 6 Gy
showed increased caspase 3 cleavage compared to samples
exposed to 6 Gy alone (Fig. 7). These data suggest that (-)-
epicatechin radiosensitizes pancreatic cancer cells by stimulating
caspase 3 expression and apoptosis.
Discussion
(-)-Epicatechin stimulated mitochondrial respiration in Panc-1
cells as evident by increased oxygen consumption rates. While (-)-
epicatechin sensitized glioblastoma and pancreatic cancer cells to
radiation, it did not sensitize HNF cells, indicating that the
radiosensitization effect of (-)-epicatechin is specific to cancer cells.
(-)-Epicatechin stimulated mitochondrial respiration and exhibited
radiosensitization in Panc-1 cells in a dose dependent manner.
Combining (-)-epicatechin with 6 Gy stimulated Chk2 phosphor-
ylation, p21 expression, and induced greater cleavage of caspase 3.
These effects were observed preferentially in cancer cells but not
normal cells (HNF).
The results shown herein are novel and significant in three
respects. Firstly, (-)-epicatechin sensitized pancreatic cancer cells to
radiation. Pancreatic cancer is typically resistant to conventional
therapeutic interventions [21] and radiosensitizing drugs may thus
be useful to overcome this therapeutic hurdle. Secondly, most
types of pancreatic cancer are characterized by Kras mutations
[22] and our results showed that (-)-epicatechin radiosensitizes
Kras mutant Panc-1 and MIA PaCa-2 cell lines. Thirdly, we
showed that (-)-epicatechin sensitized cancer cells but not HNF
cells to radiation, which is consistent with earlier studies and
indicates cancer cell selectivity [9,10,23]. Moreover, the novelty of
our results is evident in showing stimulated mitochondrial
respiration in cancer cells at concentrations that are more
therapeutically relevant and that have not been tested in
pancreatic cancer cells. Bioavailability of (-)-epicatechin when
administered orally as part of a food extract such as green tea or
cocoa may be an issue because of limited gut absorption. In this
study, we used purified (-)-epicatechin compound and envision a
more direct route of therapeutic administration in vivo that may
allow for greater plasma concentrations. Notably, our previous
studies have found biological effects after oral administration of
pure compound [14]. Although this study showed an effect of (-)-
epicatechin on normal tissue, while the current study does not,
differences in the models and cell types studied are profound and
Figure 7. (-)-Epicatechin stimulates caspase 3 cleavage and
expression in Panc-1 cells. Panc-1 cells were exposed to 0 or 20 mM
(-)-epicatechin for 1 hour, then exposed to 6 Gy of radiation, and
incubated for 72 hours. (-)-Epicatechin stimulates pro-caspase 3
expression and cleavage.
doi:10.1371/journal.pone.0088322.g007
Figure 6. (-)-Epicatechin inhibits p21 expression and does not stimulate checkpoint kinase protein 2 phosphorylation at threonine
68 in HNF cells. (A) (-)-Epicatechin inhibits p21 expression. Protein levels in 20 mM (-)-epicatechin treated samples were normalized to samples
treated with 6 Gy, and *p,0.05. (B) 20 mM (-)-epicatechin does not stimulate Chk2 phosphorylation. Protein levels in (-)-epicatechin treated samples
were normalized to samples that were treated with 6 Gy.
doi:10.1371/journal.pone.0088322.g006
Epicatechin and Pancreatic Cancer Radiotherapy
PLOS ONE | www.plosone.org 6 February 2014 | Volume 9 | Issue 2 | e88322
may account for this discrepancy. Metabolism, signaling, and ETC
isoforms are likely different between muscle cells and fibroblasts.
Stimulating mitochondrial respiration in pancreatic cancer cells
may not necessarily require increased ETC protein expression.
Numerous studies have shown that COX is decisively regulated by
phosphorylation on both the catalytic and regulatory subunits
[24]. Therefore, stimulation of mitochondrial respiration by (-)-
epicatechin in cancer cells could be mediated by a signaling
mechanism that remains to be elucidated. (-)-Epicatechin was
shown to inhibit MAPK/Erk [25,26] and MAPK was shown to
associate with EGFR and translocate to the mitochondria where it
binds to COX [27] suggesting a potential signaling mechanism for
the (-)-epicatechin-mediated regulation of mitochondrial respira-
tion.
Combining (-)-epicatechin with radiation induced Chk2 phos-
phorylation in Panc-1 cells. Chk2 phosphorylation at threonine 68
occurs following exposure to radiation as part of the DNA damage
response [28,29]. Several studies show the involvement of p21 in
radiosensitization in several types of cancer [19,20,30]. Moreover,
studies show that the phosphorylation of Chk2 at threonine 68 and
increased p21 expression reduces cell proliferation by inducing
senescence [31–33]. The ability of (-)-epicatechin to stimulate
Chk2 phosphorylation and p21 expression could potentially
explain, at least in part, a mechanism by which (-)-epicatechin
causes radiosensitization and inhibition of clonogenic survival in
Panc-1 cells. In additional, (-)-epicatechin stimulated cleavage of
caspase 3 with or without radiation and this could provide another
explanation for radiosensitization in pancreatic cancer cells.
(-)-Epicatechin stimulated mitochondrial respiration and inhib-
ited clonogenic survival in pancreatic cancer cells. When
combined with radiation, (-)-epicatechin radiosensitized pancreatic
cancer cells and glioblastoma cells, but not HNF cells. (-)-
Epicatechin stimulated Chk2 phosphorylation and p21 expression
over the level achieved by radiation alone. These findings suggest
that (-)-epicatechin is selective in sensitizing cancer cells to
radiation and makes it a promising candidate as a novel
therapeutic modality for treatment of pancreatic or other cancers.
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